H.R. 4710 would establish onerous and unnecessarily intrusive reporting requirements that stand in stark contrast to the lack of transparency of pricing practices by manufacturers. H.R. 4710, the “PAUSE” Act…
S.2312 would establish onerous and unnecessarily intrusive reporting requirements that stand in stark contrast to the lack of transparency into the pricing practices by manufacturers S.2312, “HELP” Act, was introduced…
Ryan White Clinics for 340B Access sent a letter to Ken Yeager, a member of the Santa Clara County Board of Supervisors, for his efforts to protect and preserve the…
The 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP) rule may be a delayed a fifth time. On March 27, 2018, HRSA sent to the White House Office of…
On January 24th, the New England Journal of Medicine (“NEJM”) published a study linking the 340B program to an increase in hospital-physician consolidation in the specialties of hematology-oncology and suggesting…